All that "fact check" says is that A) some people died after being vaccinated. Some from the Pfizer, Some from the AstraZeneca and a few we couldn't determine. B) Those that died were all old people, many in elder care. C) The number of deaths is lower than expected, we predicted a higher number
You know what it doesn't dispel? The question of what actually killed these people. Did they die with the vaccine or from the vaccine? These were old people, some of them were bound to die after having been vaccinated from just being old or having an existing comorbidity
It also argues that there is no need for concern because 80% of cases reporting adverse effects were actually mild and typical vaccine reactions... well what about the 20% that were not? Those 4,500 people are not relevant?
Overall... comparisons to previous years are all suspect.... of course the numbers appear alarmingly high compared to previous years, because in no other year have we ever deployed a campaign of mass public vaccination on this scale before. 1% of 100 is one death. 1% of a million is 10,000 deaths. We've never deployed millions of vaccines to the public before this pandemic. Of course the reports of complications would scale in number relative to increase scope of deployment.
There is a reason why pharmaceutical products take 3-5 years to reach the market, because they usually have to endure long public trials before being approved and deemed safe. We didn't do that for these vaccines. The reason they were able to confidently state that we'd have a vaccine by the end of 2020, in less than 12 months instead of the predicted 5 years... is because they truncated the approval process and cut out all the red-tape. They rushed it through the approval process out of necessity at the expense of the usual abundance of caution. Hence why some of the vaccines appear to have some issues with adverse reactions that would probably have been caught in normal approval trials before reaching the public.
Seriously? You are going to mass produce a new type of pharmaceutical in a very short period of time that skips over the normal trials period? Then act surprised that maybe some problems with the product slip through that have adverse effects on a portion of the public?